Strs Ohio Outlook Therapeutics, Inc. Transaction History

Strs Ohio

  • $25.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$1.22 - $2.03 $32,940 - $54,809
-27,000 Closed
0 $0
Q3 2021

Oct 22, 2021
BUY
$2.12 - $2.76 $14,204 - $18,492
6,700 Added 33.0%
27,000 $58,000
Q2 2021

Jul 26, 2021
BUY
$1.78 - $2.76 $36,134 - $56,027
20,300 New
20,300 $50,000

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $536M
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email